Modulation of Huntingtin expression

Details for Australian Patent Application No. 2010292003 (hide)

Owner Isis Pharmaceuticals, Inc. Genzyme Corporation

Inventors Hung, Gene; Bennett, C. Frank; Freier, Susan M.; Kordasiewicz, Holly; Stanek, Lisa; Cleveland, Don W.; Cheng, Seng H.; Shihabuddin, Lamya

Agent Pizzeys

Pub. Number AU-A-2010292003

PCT Pub. Number WO2011/032045

Priority 61/241,853 11.09.09 US

Filing date 10 September 2010

Wipo publication date 17 March 2011

International Classifications

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

19 April 2012 PCT application entered the National Phase

  PCT publication WO2011/032045 Priority application(s): WO2011/032045

27 September 2012 Assignment before Grant

  Genzyme Corporation; Isis Pharmaceuticals, Inc. The application has been assigned to Isis Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010292009-Dynamic transmission control for a wireless network

2010291990-Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media